Zheng, Ouyang – Trademark Portfolio

Entity Type: 01

Zheng, Ouyang holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 7 (Machinery) across 2 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include DILIB. The owner is based in Guangdong.

No.2,Yousong Donghuan 2nd RD,Longhua,

Donghuan 2nd RD,Baoan Dist,Shenzhen,

Guangdong 518000 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LAFOLIA
LAFOLIA
Pending 2025
DILIB
DILIB
Registered 2023
DILIB
DILIB
Cancelled 2018

Trademark Classifications

Zheng, Ouyang's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

7
Machinery (1 filing)

Machines and machine tools; motors and engines; machine coupling and transmission components

Frequently Asked Questions

How many trademarks does Zheng, Ouyang have?

Zheng, Ouyang has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending, 1 cancelled.

What trademark classes does Zheng, Ouyang file in?

Zheng, Ouyang files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 7 (Machinery). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Zheng, Ouyang's most well-known trademarks?

Zheng, Ouyang's registered trademark portfolio includes well-known marks such as DILIB. These are among 1 currently registered trademark in the portfolio.

What is Zheng, Ouyang's trademark registration success rate?

Zheng, Ouyang has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.